Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
3billion | RCV002283920 | SCV002573124 | pathogenic | Polycystic kidney disease 2 | 2022-09-01 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. This stop-gained (nonsense) variant is predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported to be associated with PKD2-related disorder (PMID: 31740684). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. |
Fulgent Genetics, |
RCV002283920 | SCV005668037 | pathogenic | Polycystic kidney disease 2 | 2024-05-29 | criteria provided, single submitter | clinical testing |